• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高血压管理中的陷阱——诊断与治疗中的误判]

[Pitfalls in hypertension management--misjudgements in diagnosis and therapy].

作者信息

Scholze J, Rautenberg B, Hansen A

机构信息

Medizinische Universitätspoliklinik Charité, Berlin, Germany.

出版信息

Dtsch Med Wochenschr. 2002 Nov 8;127(45):2383-6. doi: 10.1055/s-2002-35361.

DOI:10.1055/s-2002-35361
PMID:12422296
Abstract

HISTORY AND CLINICAL FINDINGS

A 71-year-old woman with arterial hypertension, diabetes type 2, peripheral vascular disease and Sjögren's syndrome presented with progressive weakness, dizziness, insomnia, palpitations and headache. These symptoms did not improve by changing her antihypertensive treatment. The patient's general condition was quite normal and there were no signs of acute or chronic cardiopulmonary decompensation.

INVESTIGATIONS

Besides arterial hypertension, she also had an elevated body mass index, dyslipoproteinemia, microalbuminuria, diabetic metabolism, left ventricular hypertrophy with signs of an abnormal diastolic cardiac function as well as atherosclerotic lesions (in both carotid arteries) which were identified as the patient's cardiovascular risk factors. Ambulant blood pressure monitoring revealed decreasing BP values for a period of 5 hrs after drug intake but, subsequently, severe hypertensive values (up to 220 mmHg systolic) without adequate decrease at night. Moreover, a hyperkinetic regulation of her circulation was demonstrated by hemodynamic monitoring and assessment of the autonomic nervous system.

TREATMENT

By changing drug treatment, i. e. administration of an anti-adrenergic calcium antagonist of the non-dihydropyridine type combined with an ACE inhibitor and a diuretic, respectively, (both given in fixed combinations) led to the normalization of the blood pressure and pulse rate as well as an improvement of the patient's condition.

CONCLUSIONS

This case emphasizes the importance of ambulant blood pressure monitoring and an assessment of the heart rate in individually adapted antihypertensive drug therapy. The application of metabolically neutral fixed drug combinations with special regard to associated diseases, organ protection and the patient's compliance resulted in normotensive blood pressure values and an improvement of the quality of life.

摘要

病史与临床发现

一名71岁女性,患有动脉高血压、2型糖尿病、周围血管疾病和干燥综合征,出现进行性虚弱、头晕、失眠、心悸和头痛。改变抗高血压治疗方案后,这些症状并未改善。患者的一般状况相当正常,没有急性或慢性心肺失代偿的迹象。

检查

除动脉高血压外,她还存在体重指数升高、血脂蛋白异常血症、微量白蛋白尿、糖尿病代谢、左心室肥厚并有舒张性心功能异常的迹象,以及(双侧颈动脉)动脉粥样硬化病变,这些被确定为患者的心血管危险因素。动态血压监测显示,服药后5小时血压值下降,但随后出现严重高血压值(收缩压高达220 mmHg),夜间血压没有充分下降。此外,通过血流动力学监测和自主神经系统评估显示她的循环存在高动力调节。

治疗

通过改变药物治疗,即分别给予非二氢吡啶类抗肾上腺素能钙拮抗剂与一种ACE抑制剂和一种利尿剂(两者均以固定组合给药),使血压和脉搏率恢复正常,并改善了患者的状况。

结论

该病例强调了动态血压监测和心率评估在个体化调整抗高血压药物治疗中的重要性。应用对代谢无不良影响的固定药物组合,并特别关注相关疾病、器官保护和患者依从性,可使血压值恢复正常并改善生活质量。

相似文献

1
[Pitfalls in hypertension management--misjudgements in diagnosis and therapy].[高血压管理中的陷阱——诊断与治疗中的误判]
Dtsch Med Wochenschr. 2002 Nov 8;127(45):2383-6. doi: 10.1055/s-2002-35361.
2
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
3
[Hypertensive emergency and urgence].[高血压急症与亚急症]
Herz. 2003 Dec;28(8):717-24. doi: 10.1007/s00059-003-2506-8.
4
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
5
[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].[原发性高血压患者治疗后昼夜血压及影响因素分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4.
6
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?肾素-血管紧张素系统抑制对靶器官保护的作用:我们能否做得更好?
Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019.
7
[Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].[心血管风险分层。收缩压、舒张压还是脉压?]
Ital Heart J Suppl. 2001 Apr;2(4):356-8.
8
Treatment of hypertension in chronic kidney disease.慢性肾脏病高血压的治疗
Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016.
9
Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.马尼地平/地拉普利与氯沙坦/氢氯噻嗪固定复方制剂治疗高血压合并糖尿病患者的疗效比较
J Hypertens. 2008 Apr;26(4):813-8. doi: 10.1097/HJH.0b013e3282f3b5f0.
10
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.α受体阻滞剂多沙唑嗪作为高血压合并糖代谢受损患者附加治疗的临床疗效及耐受性
Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. doi: 10.1016/j.numecd.2005.04.005. Epub 2005 Oct 20.